NCT02860234View on ClinicalTrials.gov

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions

Rectal Cancer

Interventions

DRUG

Oxaliplatin

DRUG

Capecitabine

RADIATION

intensity modulated radiotherapy

PROCEDURE

DRE-Endoscopy-MRI-CEA

PROCEDURE

Nonoperative Management

PROCEDURE

Local Excision

PROCEDURE

Total Mesorectal Excision

BEHAVIORAL

Quality of Life Questionnaires

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Peking University Cancer Hospital & Institute

OTHER

NCT02860234 - Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment | Biotech Hunter | Biotech Hunter